摘要:
The invention provides the use of optically pure (S,S)-reboxetine, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment or prevention of attention deficit (or other cognitive disorders) due to general medical conditions.
摘要:
The invention provides the use of optically pure (S,S)-reboxetine, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment or prevention of age associated learning and mental disorders.
摘要:
The invention provides the use of optically pure (S,S)-reboxetine, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment or prevention of age associated learning and mental disorders.
摘要:
The use of racemic reboxetine, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment or prophylaxis of chronic fatigue syndrome, is disclosed.
摘要:
The use of racemic reboxetine, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment or prophylaxis of chronic fatigue syndrome, is disclosed.